Form 4: NEUROONE MEDICAL TECHNOLOGIES Executive Receives Stock Grant
Insider Transaction (Form 4)
Mark Christianson, Market Development Director of NEUROONE MEDICAL TECHNOLOGIES Corp, received 12,500 shares of common stock on August 28, 2026.
Summary
- Grant/award: acquired 12,500 Option to Purchase Common Stock on August 28, 2026; holds 12,500 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Mark Christianson — Officer (Market Development Director)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-28 | Grant/award | Option to Purchase Common Stock | 12,500 | — | — | 12,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-28 | Grant/award (12,500 shares) |
Keywords
insider transaction, Form 4, NMTC, NEUROONE MEDICAL TECHNOLOGIES Corp, neutral, Mark Christianson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.